Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery

Circulation

Volumn 92, Issue 9 SUPPL., 1995, Pages

  Teoh, Kevin H T ^a,b   Bradley, Christine A ^a   Gauldie, Jack ^a   Burrows, Heather ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

cardiopulmonary bypass; cytokines; steroids

Indexed keywords

CORTICOSTEROID; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE SODIUM SUCCINATE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME IMMUNOASSAY; FEMALE; HEART SURGERY; HEMODYNAMIC MONITORING; HORMONE ACTION; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; VASODILATATION;

EID: 0028844569     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.92.9.347     Document Type: Article

References (45)

1. Kirklin JK, McGiffin DC. Early complications following cardiac surgery. Cardiovasc Clin. 1987;17:321-342.
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
3. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock RR, Joacob HS. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81: 370-377.
4. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement in the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-857.
5. van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpentier A, Wildevuur CRH. Deleterious effects of cardiopulmonary bypass: a perspective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg. 1985;89:889-899.
6. Howard RJ, Crain C, Franzini DA, Hood I, Hugli TE. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg. 1988;123:1496-1501.
7. Kushner I. The phenomena of the acute phase response. Ann N Y Acad Sci. 1982;389:39-48.
8. Dinarello CA. Interleukin-1 and the pathogenesis of the acute phase response. N Engl J Med. 1984;311:1413-1418.
9. Jansen NJG, van Oeveren W, van den Broek L, Oudemans-van Straaten HM, Stoutenbeek CP, Joen MC, Roozendaal KJ, Eysman L, Wildevuur CRH. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102:515-525.
10. Ratliff NB, Young WG Jr, Hackel DB, Mikat E, Wilson JW. Pulmonary injury secondary to extracorporeal circulation: an ultrastructural study. J Thorac Cardiovasc Surg. 1993;65:425-432.
11. Cavarocchi NC, Pluth JR, Schaff HV, Orszulak TA, Homburger HA, Solis E, Kaye MP, Clancy MS, Koltt J, Deeb GM. Complement activation during cardiopulmonary bypass: comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg. 1986;91: 252-258.
12. Schroder JM, Mrowietz R, Christophers E. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol. 1988;140: 3534-3540.
13. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med. 1988;167:1364-1376.
14. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045-1049.
15. Van Damme J. Interleukin-8 and related molecules. In: Thomson AW, ed. The Cytokine Handbook: Immunology and Molecular Biology of Cytokines. London, England: Academic Press Ltd; 1991: 201-214.
16. Rot A. Some aspects of NAP-1 pathophysiology: lung damage caused by a blood-borne cytokine. In: Westwick J, ed. Chemotactic Cytokines. New York, NY: Plenum Press; 1991:127-135.
17. Toledo-Pereyva LH, Lin GY, Kundler H, Replogle RL. Steroids in heart surgery: a clinical double-blind and randomized study. Am Surg. 1980;46:155-160.
18. Christakis GT, Koch JP, Deemar KA, Fremes SE, Sinclair L, Chen E, Salerno TA, Goldman BS, Lichenstein SV. A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg. 1992;54:449-459.
19. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;108: 636-641.
20. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.
21. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine response to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg. 1992;53:833-838.
22. Kawamura T, Wakusaw R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993;40:1016-1021.
23. Almdahl SM, Waage A, Ivert T, Vaage J. Release of bioactive interleukin 6 but no tumor necrosis factor-α after elective cardiopulmonary bypass. Perfusion. 1993;8:233-238.
24. Jorens PG, de Jongh R, de Backer W, Van Damme J, van Overveld F, Bossaert L, Walter P, Herman AG, Rampart M. Interleukin-8 production in patients undergoing cardiopulmonary bypass: the influence of pretreatment with methylprednisolone. Am Rev Respir Dis. 1993;148:890-895.
25. Haeffner-Cavaillon N, Roussellier N, Ponzio O, Carreno MP, Laude M, Carpentier A, Kazatchkine MD. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1989;98:1100-1106.
26. Moore FD, Warner KG, Assousa S, Valeri CR, Khuri SF. The effects of complement activation during cardiopulmonary bypass. Ann Surg. 1988;208:95-103.
27. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg. 1993; 105:25-30.
28. Markewitz A, Faist E, Lang S, Endres S, Hultner L, Reischart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg. 1993;55:389-394.
29. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliot M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105: 234-241.
30. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg. 1992;54: 744-748.
31. Laidler J, Paes ML, Wheeler J, Freeman R, Robertson H. Detection of circulating tumour necrosis factor-α after elective cardiopulmonary bypass. Perfusion. 1991;6:51-54.
32. Dauber IM, Parsons PE, Welsh CH, Giclas PC, Whitman GJ, Wheeler GS, Horwitz LD, Weil JV. Peripheral bypass-induced pulmonary and coronary vascular injury: association with increased levels of tumor necrosis factor. Circulation. 1993;88:726-735.
33. Lehot JJ, Villard J, Piriz H, Philbin DM, Carry PY, Gauquelin G, Claustrat B, Sassolas G, Galliot J, Estanove S. Hemodynamic and hormonal responses to hypothermic and normothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1992;6:132-139.
34. 4 by human alveolar and peritoneal macrophages in culture. Clin Sci. 1984;67:653-656.
35. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS. Relationship of proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994;108:626-635.
36. Faymonvill ME, Pincemail J, Duchateau J, Paulus JM, Adam A, Deby-Dupont G, Deby C, Albert A, Larbuisson R, Limet R, Lamy M. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg. 1991;102:309-317.
37. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM. Increased production of peroxidation products associated with cardiac operations: evidence for free radical generation. J Thorac Cardiovasc Surg. 1986;91:759-766.
38. Bator JM, Gillinov AM, Zehr KJ. NPC 15669 blocks neutrophil CD18 increase and lung injury during cardiopulmonary bypass in pigs. Medial Inflammation. 1993;2:135-141.
39. Byrne JG, Smith WJ, Murphy MP, Couper GS, Appleyard RF, Cohn LH. Complete prevention of myocardial stunning, contracture, low-refow, and edema after transplantation ly blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg. 1992;194:1589-1596.
40. Goldman G, Welbourn R, Rothlein R, Wiles M, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Adherent neutrophils mediate permeability after atelectasis. Ann Surg. 1992;216:372-380.
41. Tennenberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery. 1986; 100:134-141.
42. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic in the lung. Exp Lung Res. 1991;17:17-23.
43. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993;365: 654-657.
44. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock RR, Jaocob HS. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81: 370-377.
45. Jorens PG, de Jongh R, de Backer W, van Damme J, van Overveld F, Bossaert L, Walter P, Herman AG, Rampart M. Interleukin-8 production in patients undergoing cardiopulmonary bypass: the influence of pretreatment with methylprednisolone. Am Rev Respir Dis. 1993;148:890-895.